Rank #1701VIR

Vir Biotechnology, Inc.

$7.82

-0.13% (Daily)

Market Cap

$1.09B

Revenue

$16.86M

Rank by MCap

#1701

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.

Headquarters

San Francisco, CA

Employees

408

About Vir Biotechnology, Inc.

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human me...